Physician profile
Daniel Alan Pedersen
NPI 1619327780
$2,455.88
in general payments reported to CMS, 2019-2025
18 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.05 · 2021: $424 · 2022: $630 · 2023: $414 · 2024: $790 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $606.03 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $511.68 | 2021-2024 | Xarelto |
| Abbvie INC. | $296.84 | 2022-2025 | |
| Glaxosmithkline, LLC. | $232.15 | 2020-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $223.03 | 2021-2025 | Mounjaro, Emgality, Zepbound |
| Pfizer INC. | $201.31 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.19 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.13 | 2022-2023 | Xifaxan |
| Lucid Diagnostics INC. | $37.35 | 2023-2024 | |
| Inspire Medical Systems, INC. | $29.66 | 2024 | Inspire |
| Fidia Pharma USA INC. | $28.69 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| E.R. Squibb & Sons, L.L.C. | $28.39 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $27.70 | 2023 | |
| Novo Nordisk INC | $24.38 | 2022 | |
| Merck Sharp & Dohme LLC | $24.17 | 2025 | Capvaxive |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $23.20 | 2022 | |
| Exact Sciences Corporation | $20.07 | 2025 | Cologuard Collection Kit |
| Bioventus LLC | $15.91 | 2023 | Supartz Fx Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pedersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.